Skip to main content

DDD

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Zimmer Biomet
Zimmer BiometFL - Jacksonville
1 program
MaxAn Post Market Surveillance ValidationN/A1 trial
Active Trials
NCT01343693Completed119Est. Jan 2018
Spine BioPharma
Spine BioPharmaNY - New York
1 program
The PerX360º System™ RegistryN/A1 trial
Active Trials
NCT01796535Unknown125Est. Jun 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Spine BioPharmaThe PerX360º System™ Registry
Zimmer BiometMaxAn Post Market Surveillance Validation

Clinical Trials (2)

Total enrollment: 244 patients across 2 trials

NCT01796535Spine BioPharmaThe PerX360º System™ Registry

The PerX360º System™ Registry

Start: Nov 2012Est. completion: Jun 2013125 patients
N/AUnknown
NCT01343693Zimmer BiometMaxAn Post Market Surveillance Validation

MaxAn Post Market Surveillance Validation

Start: Jun 2011Est. completion: Jan 2018119 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.